Transitioning from Insulin Drip to Subcutaneous Insulin in DKA Management

Criteria for DKA Resolution Before Transition

• The American Diabetes Association recommends that blood glucose should be less than 200 mg/dL, serum bicarbonate should be greater than or equal to 18 mEq/L, and venous pH should be greater than 7.3 before considering transition from IV to subcutaneous insulin 1, 2
• Clinical improvement, such as the patient being alert and able to tolerate oral intake, is also a criterion for transition 3

Calculating Subcutaneous Insulin Doses

• The total daily insulin requirement can be calculated by multiplying the hourly insulin drip rate by 24 hours, for example, 7 units/hour × 24 hours = 168 units/day 4
• The basal insulin dose can be calculated as 40-50% of the total daily dose, which would be 67-84 units for a total daily dose of 168 units 3, 4

Transition Protocol

• The American Diabetes Association recommends administering basal insulin 2-4 hours before stopping the IV insulin infusion to prevent rebound hyperglycemia and recurrence of ketoacidosis 3, 5
• It is recommended to continue IV insulin for 1-2 hours after administering subcutaneous insulin to ensure adequate plasma insulin levels 3, 5

Monitoring During Transition

• Blood glucose should be checked every 2-4 hours while the patient is NPO, and monitoring should continue until the patient is able to eat and their glucose levels are stable 3, 6
• Electrolytes, especially potassium, should be monitored as insulin can cause hypokalemia 7

Common Pitfalls to Avoid

• Abrupt discontinuation of IV insulin without overlapping with subcutaneous insulin can lead to rebound hyperglycemia, and inadequate basal insulin coverage during transition can also cause hyperglycemia 1, 3
• Failure to monitor electrolytes, particularly potassium, can lead to hypokalemia and other complications 8

Special Considerations

• For patients with type 1 diabetes, resumption of their previous insulin regimen at hospital doses is essential to prevent rebound hyperglycemia and ketoacidosis 4
• A structured discharge plan should be developed for patients with new-onset diabetes, including education on insulin administration and glucose monitoring 3